Angioimmunoblastic Lymphadenopathy: Comprehensive Review

References

• Frizzera G, Moran EM, Rappaport H. Angioimmunoblastic lymphadenopathy with dysproteinemia. Lancet 1974; i: 1070–1073
   Google Scholar
• Frizzera G, Moran EM, Rappaport H. Angioimmunoblastic lymph-adenopathy: diagnosis and clinical course. Am J Med 1975; 59: 803–818
   PubMed Web of Science ®Google Scholar
• Lukes RJ, Tindle BH. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease. N Engl J Med 1975; 292: 1–8
   PubMed Web of Science ®Google Scholar
• Stensvold K, Brandtzaeg P, Kval YS, et al. Immunoblastic lymph-adenopathy with early onset in two boys: immunohistochemical study and indication of decreased proportion of circulating T-helper cells. Br J Haematol 1984; 56: 417–430
   PubMed Web of Science ®Google Scholar
• Fiorillo A, Pettiwto G, Raia V, et al. Angioimmunoblastic lymphadenopathy with dysproteinemia: report of the first case in childhood evolving toward spontaneous remission. Cancer 1981; 48: 1611–1614
   PubMed Web of Science ®Google Scholar
• Geha RS, Perez Atayde AR, Griscom T, et al. A 10 year old boy with progressive lymphadenopathy, fever and rash. Ann Allergy 1984; 53: 381–389
   PubMedGoogle Scholar
• Howarth CB, Bird CC. Immunoblastic sarcoma arising in a child with immunoblastic lymphadenopathy. Lancet 1976; 2: 747–748
   PubMed Web of Science ®Google Scholar
• Chodirker WB, Komar RR. Angioimmunoblastic lymphadenopathy in a child with unusal clinical immunologic features. I Allergy Clin Immunol 1985; 76: 745–752
   PubMed Web of Science ®Google Scholar
• Morris JA, Bird CC. Ultrastructural and immunohistological study of immunoblastic sarcoma developing in child with immunoblastic lymphadenopathy. Cancer 1979; 44: 171–182
   PubMed Web of Science ®Google Scholar
• Bernengo MG, Levi L, Zina G. Skin lesions in angioimmunoblastic lymphadenopathy: histological and immunological studies. Br J Dermatol 1981; 104: 131–139
   PubMed Web of Science ®Google Scholar
• Bernstein JE, Soltani K, Lorinez AL. Cutaneous manifestations of angioimmunoblastic lymphadenopathy. J Am Acad Dermatol 1979; 1: 227–232
   PubMed Web of Science ®Google Scholar
• Meijer CJ, Scheffer E, Lauw GP, et al. Skin biopsy in angioimmunoblastic lymphadenopathy. Lancet 1978; i: 771–772
   Google Scholar
• Seehafer JR, Goldberg NC, Dicken CH, et al. Cutanems manifestations of angioimmunoblastic lymphadenopathy. Arch Dermatol 1980; 116: 41–45
   PubMed Web of Science ®Google Scholar
• Wechsler HL, Stavrides A. Immunoblastic lymphadenopathy with purpura and cryoglobulimmia. Arch Dermatd 1977; 113: 636–641
   PubMed Web of Science ®Google Scholar
• Al Hilali M, Joyner MV. Pure red cell aplasia secondary to angioimmunoblastic lymphadenopathy. J Roy Soc Med 1983; 76: 894–895
   PubMed Web of Science ®Google Scholar
• Blurning AZ, Cohen HG, Sexon A. Angioimmunoblastic lymphadenopathy with dysproteinemia: a pathogenic link between physiologic lymphoid proliferation and malignant lymphoma. Am J Med 1979; 67: 421–428
   PubMed Web of Science ®Google Scholar
• Bradley SL, Dines DE, Banks PM, et al. The lung in inununob-lastic lymphadenopathy. Chest 1981; 80: 313–318
   Web of Science ®Google Scholar
• Cassoli M, Bergmaschi G., Castello A, et al. Kaposi's sarcoma complicating immunosuppressive therapy for angioimmunoblastic lymphadenopathy with dysproteinemia. Tumor 1982; 68: 537–542
   PubMed Web of Science ®Google Scholar
• Spector JI, Miller S. Immunoblastic lymphadenopathy: a report of two cases. J Am Med Assoc 1977; 238: 1263–1265
   Web of Science ®Google Scholar
• Trenchard PM, Whittaker JA, Gough J, et al. Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy: possible contributions of immunoblastic leukemia, chemotherapy and multiple antibodies directed against mature blood cells. J Clin Pathol 1981; 34: 486–494
   PubMed Web of Science ®Google Scholar
• Garner SC, Lehr-Janus C, Efremidis SC. Angioimmunoblasric lymphadenopathy with dysproteinemia: masquerader of lymphoma. NY State J Med 1981; 81: 1663–1666
   PubMedGoogle Scholar
• Weisenburger DD. Immunoblastic lymphadenopathy Associated with methyldopa therapy. A case report. Cancer 1978; 42: 2322–2327
   PubMed Web of Science ®Google Scholar
• Brenner B., Green J., Rosenbaum H, et al. Severe pancytopenia due to marked marrow fibrosis Associated with angioimmunoblastic lymphadenopathy. Acta Haematol 1985; 74: 43–44
   PubMed Web of Science ®Google Scholar
• Snustad DG, Koss W, Fontana JW. Angioimmunoblastic lymphadenopathy with associated selective myeloid hypoplasia. Cancer 1984; 53: 2129–2134
   PubMed Web of Science ®Google Scholar
• Crerners S., Dutrieux-Fauchet MC, Dutrieux C. Bronchioloalveolar carcinoma in angioimmunoblastic lymphadenopathy. Eur J Respir Dis 1983; 64: 222–228
   PubMedGoogle Scholar
• Cunningham JJ, Jackson DV. Lymphographic and echographic findings in angioimmunoblastic lymphadenopathy. Arch Intern Med 1977; 137: 1693–1695
   PubMed Web of Science ®Google Scholar
• Horne CHW, Fraser RA. Petrie JC: Angioimmunoblastic lymphadenopathy with dysproteinemia. Lancet 1974; 2: 291
   PubMed Web of Science ®Google Scholar
• Kucuk O., Gynn TN. Angioimmunoblastic lymphadenopathy with cholestasis and intravascular coagulation. Clin Oncol 1982; 8: 273–278
   PubMed Web of Science ®Google Scholar
• Minerbrook M., Budman DR, Schulman P, et al. De novo disseminated intravascular coagulation in angioimmunoblastic lymphadenopathy (AILD). Cancer 1983; 51: 1927–1930
   PubMed Web of Science ®Google Scholar
• Moreb J, Okan E, Matzner Y, et al. Angioimmunoblastic lymphadenopathy. A case with an unusual clinical course with marked tumorous infiltration of multiple organs and striking intestinal involvement. Cancer 1983; 51: 487–491
   PubMed Web of Science ®Google Scholar
• Raskin RJ, Tesar JT, Lawless OJ. Polyarthritis in immunoblaatic lymphadenopathy. Arthritis Rheum 1982; 25: 1481–1485
   PubMed Web of Science ®Google Scholar
• Weisenburger D, Armitage J, Dick F. Immunoblastic lymphadenopathy with pulmonary infiltrates. hypocomplementemia and vasculitis: a hyperimmune syndrome. Am J Med 1977; 63: 849–854
   PubMed Web of Science ®Google Scholar
• Brearley RL, Chapman J, Cullen MH, et al. Haematological features of angioimmunoblastic lymphadenopathy with dysproteinemia. J Clin Pathol 1979; 32: 356–360
   PubMed Web of Science ®Google Scholar
• Brincker H, Birkeland SA. The relationship between disease activity. treatment response and immunologic reactivity in immunoblastic lymphadenopathy: a longitudinal study of treatment with levamisole and cytostatics. Lancet 1981; 47: 266–271
   Google Scholar
• Cibull ML, Seligson GR, Mouradian JA, et al. Immunoblastic lymphadenopathy and adenocarcinorna of the pancreas: a case report. Cancer 1978; 42: 1883–1885
   PubMed Web of Science ®Google Scholar
• Joshi K, Srinivasa R, Shankar SK. Immunoblastic lymphadenopathy—report of a case. Postgrad Med J 1978; 54: 672–675
   PubMed Web of Science ®Google Scholar
• Park CH, Ceron G. Scintigraphic findings in angioinimunoblastic lymphadenopathy. J Nucl Med 1980; 21: 188–190
   PubMed Web of Science ®Google Scholar
• Schauer PK, Straua DJ, Bagley CM, et al. Angioimmunoblastic lymphadenopathy: clinical spectrum of disease. Cancer 1981; 48: 2493–2498
   PubMed Web of Science ®Google Scholar
• Aizawa Y, Zawadzki ZA, Micoloughi TS, et al. Vasculitia and Sjogren's syndrome with IgA-IgG cryoglobulinemia terminating in immunoblaslic sarcoma. Am J Med 1979; 67: 160–166
   PubMed Web of Science ®Google Scholar
• Gordon BR, Suthanthiran M, Saal SD, et al. Plasmapheresis in a patient with angioimmunoblastic lymphadempathy. Improvement in clinical and immunologic abnormalities. Cancer 1983; 51: 829–833
   PubMed Web of Science ®Google Scholar
• Nathwani BN, Rappaport H, Moran EM, et al. Malignant lymphoma arising in angioimmunobiastic lymphadenopathy. Cancer 1978; 41: 578–606
   PubMed Web of Science ®Google Scholar
• Rice L, Abramson SL, Laughter AH, et al. Angioimmunoblastic lymphadenopathy with hypogammaglobulinemia. Possible role of monocyte supprewon. Am J Med 1982; 72: 998–1004
   PubMed Web of Science ®Google Scholar
• Starke ID, Elkon KB, Harmer CL, et al. Pulmonary involvement in angioimmunoblastic lymphadenopathy following autoimmune disease. Respirdtion 1983; 44: 136–142
   PubMed Web of Science ®Google Scholar
• Hatty S, Mufti GJ, Hamblin TJ. Anglo-immunoblastic lymphadenopathy with hypogammaglobulinaemia complicated by miliary tuberculosis. Acta Haematol 1985; 73: 37–39
   PubMed Web of Science ®Google Scholar
• Loo SYT, Bhagavan NV, Scottolini AG. Polyclonal gammopathy with B-globulin-globulin bridging. Arch Pathol Lab Med 1981; 105: 98–101
   PubMed Web of Science ®Google Scholar
• Bamberg M, Donhuijsen K, Hoher PG, et al. Malignant progression of angioimmunoblastic lymphadenopathy. J Cancer Res Clin Oncol 1979; 93: 255–263
   PubMed Web of Science ®Google Scholar
• Bauer TW, Mendelsohn G, Humphrey RL, et al. Angioimmunoblastic lymphadenopathy progressing to immunoblastic lymphoma with prominent gastric involvement. Cancer 1982; 50: 2089–2098
   PubMed Web of Science ®Google Scholar
• Jones DB, Castleden M, Smith JL, et al. Immunopathology of angioimmunoblastic lymphadenopathy. Br J Cancer 1978; 37: 1053–1062
   PubMed Web of Science ®Google Scholar
• Naparstek Y, Ben-Chetrit E, Okon E, et al. Angioimmunoblastic lymphadenopathy in a patient with allergy to insulin: a case report Cancer. 1981; 47: 545–547
   Google Scholar
• Budman DR, Koziner B, Cunningham-Rundles C, et al. IgA deficiency associated with angioimmunoblasric lymphadenopathy. N Engl J Med 1978; 298: 1204
   PubMed Web of Science ®Google Scholar
• Wasser WG, Bockman RS, Alderete M, et al. Immunoblastic lymphadenopathy with hypercalcenia. Mt Sinai I Med 1980; 47: 13–16
   PubMed Web of Science ®Google Scholar
• Cooperberg AA. Immumblastic lymphadenopthy. case report and literature review. Can Med Assoc J 1977; 117: 53–57
   PubMed Web of Science ®Google Scholar
• Pruzanski W, Sutton DMC, Pantalomy D. Angioimmunoblastic lymphadenopathy: an immunochemical study. Clin Immunol Immunopath 1976; 6: 62–76
   PubMedGoogle Scholar
• Schulman P, Budman DR, Vinciguerra VP, et al. B-cell activation in angioimmunoblastic lymphadenopathy after inimunization with multivalent pneunmcoccal polysaccharide vaccine. Lancel 1979; 2: 1141
   PubMed Web of Science ®Google Scholar
• Boros L, Bhaskar AG, D'Souza JP. Monoclonal evolution of angioimmunoblastic lymphadenopathy. Am J Clin Pathol 1981; 75: 856–860
   PubMed Web of Science ®Google Scholar
• Klajman A, Yaretzky A, Schneider M, et al. Angioimmunoblastic lymphadenopathy with paraproteinemia: a T- and B-cell disorder. Cancer 1981; 48: 2433–2437
   PubMed Web of Science ®Google Scholar
• Rahmani R, Brenner S, Krakowski A, et al. Angioimmunoblastic lymphadenopathy with scleroderma-like lesions and serum monoclonal protein. Isr J Med Sci 1983; 19: 235–239
   PubMedGoogle Scholar
• Lapes MJ, Vivacqua RV, Antoniades K. Immunoblastic lymphadenopathy associated with phenytoin (diphenylhydantoin). Lancet 1976; 198
   PubMed Web of Science ®Google Scholar
• Tangun Y, Saracbasi Z, Pekcelen Y, et al. Angioimmunoblastic lymphadenopathy with dysproteinemia. Lancet 1974; i: 1345–1346
   Google Scholar
• Gusterson BA, Fitzhams BM. Angioimmunoblastic lymphadenopathy with lupus erythematosus cells. Br J Haematol 1979; 43: 149–150
   PubMed Web of Science ®Google Scholar
• Colbert N, Andrieu JM. Hyponatremia associated with angioimmunoblastic lymphadenopathy. Acta Haematol 1983; 70: 389–391
   PubMed Web of Science ®Google Scholar
• Gan E, van der Weyden MB. Hypercalcemia and angioimmunoblastic lymphadenopathy. Br Med J 1981; 282: 437
   PubMed Web of Science ®Google Scholar
• Sogaard PE, Molin J. Nephrocalcinosis in angioimmunoblastic lymphadenopathy. A case report. Acta Med Scand 1982; 211: 319–320
   PubMed Web of Science ®Google Scholar
• Sworn MJ, Buchanan R, McGill DA. Angioimmunoblastic lymphadenopathy and hypercalcemia. J Clin Pathol 1979; 32: 1072
   PubMed Web of Science ®Google Scholar
• Iseman MD, Schwartz MI, Standord RE. Interstitial pneumonia in angioimmunoblastic lymphadenopathy with dysproteinemia. Ann Intern Med 1976; 85: 752–755
   PubMed Web of Science ®Google Scholar
• Khouri NF, Eggleston JD, Siegelman SS. Angioimmunoblastic lymphadenopathy: a cause for mediastinal nodal enlargement. Am J Roentgenol 1978; 130: 1186–1188
   PubMed Web of Science ®Google Scholar
• Limpert J, MacMahon H, Variakojis D. Angioimmunoblastic lymphadenopathy: clinical and radiological features. Radiology 1984; 152: 27–30
   PubMed Web of Science ®Google Scholar
• Myers TJ, Cole SR, Pastuszak WT. Angioimmunoblastic lymphadenopathy: pleural-pulmonary disease. Cancer 1978; 41: 266–271
   PubMed Web of Science ®Google Scholar
• Siegler D, Winner S. Pulmonary and pleural involvement in angioimmunoblastic lymphadenopathy. Br J Dis Chest 1980; 74: 296–300
   PubMedGoogle Scholar
• Zylak CJ, Banerjee R, Galbraith PA, et al. Lung involvement in angioimmunoblastic lymphadenopathy (AIL). Radiology 1976; 121: 513–519
   PubMed Web of Science ®Google Scholar
• Bruneton JN, LeTreut A, de Mascarel HA, et al. Lymphography in angioimmunoblastic lymphadenopathy. Br J Radiol 1979; 52: 110–115
   PubMed Web of Science ®Google Scholar
• Libshitz HI, Clouser M, Zornoza J, et al. Radiographic findings of immunoblastic lymphadenopathy and related immunoblastic proliferations. Am J Roentgenol 1979; 129: 875–878
   Web of Science ®Google Scholar
• Bennum RR, Costello P. CT findings in angioimmunoblastic lymphadenopathy. J Comput Assist Tomogr 1983; 7: 454–456
   PubMed Web of Science ®Google Scholar
• Tishler M, Solomon A, Greif J, et al. Pulmonary changes in angioimmunoblastic lymphadenopathy as demonstrated by computerized tomography. Comp Radiol 1985; 9: 159–162
   PubMedGoogle Scholar
• Gill SP, Thrall JH, Beaucbamp ML, et al. Gallium-67 citrate concentration in angioimmunoblastic lymphadenopathy with dys-proteinemnia. J Nucl Med 1977; 18: 312–313
   PubMed Web of Science ®Google Scholar
• Lukes RJ, Tindle BH. Immunoblastic lymphadenopathy: a pre-lymphomatous state of immunoblastic sarcoma. Rec Res Cancer Res 1978; 64: 235–240
   PubMedGoogle Scholar
• Dameshek W. “Immunoblasts” and “immunocytes”—an attempt at a functional nomenclature. Blood 1963; 21: 243–245
   PubMed Web of Science ®Google Scholar
• Neiman RS, Dervan P, Haudenschild C, et al. Angioimmunoblastic lymphadenopathy. An ultrastructural and immunologic study with review of the literature. Cancer 1978; 41: 507–518
   PubMed Web of Science ®Google Scholar
• Ough YD, Miller WM, Leeb B, et al. Immunoblastic lymphoma with extracellular and intravascular immunoglobulin deposits. immunocytochemical and electron microscopic studies. Cancer 1983; 51: 623–630
   PubMed Web of Science ®Google Scholar
• Palutke M, Khilanani P, Weise R. Immunologic and electron microscopic characteristics of a case of immunoblastic lymphadenopathy. Am J Clin Pathol 1976; 65: 929–941
   PubMed Web of Science ®Google Scholar
• Ghani AM, Krause JR. Bone marrow biopsy findings in angioimmunoblastic lymphadenopathy. Br J Haematol 1985; 61: 203–213
   PubMed Web of Science ®Google Scholar
• Pangalis GA, Moran EM, Rappaport H. Blood and bone marrow findings in angioimmunoblastic lymphadenopahy. Blood 1978; 51: 71–83
   PubMed Web of Science ®Google Scholar
• Schnaidt U, Vykoupil KF, Thiele J, et al. Angioimmunoblastic lymphadenopathy. Histopathology of bone marrow involvement. Virchows Arch Pathol Anat 1980; 389: 369–380
   PubMedGoogle Scholar
• Fisher RI, Jaffe ES, Braylon RC, et al. Immunoblastic lymphadenopathy. Evolution into a malignant lymphoma with plasma-cytoid features. Am J Med 1976; 61: 553–559
   PubMed Web of Science ®Google Scholar
• Matloff RB, Neiman RS. Angioimmunoblastic lymphadenopathy. A generalized lymphoproliferative disorder with cutaneous manifestations. Arch Dermatol 1978; 114: 92–94
   PubMed Web of Science ®Google Scholar
• Abu-Zahra HT, McDonald DB, Home WI. Angioimmunoblastic lymphadenopathy with dysproteinemia. Lancet 1975; i: 1114–1115
   Google Scholar
• Kaneko Y, Laron RA, Variakojis D, et al. Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy. Blood 1982; 60: 877–887
   PubMed Web of Science ®Google Scholar
• Matz LR, Papadimitriou JM, Carroll JR, et al. Angioimmunoblastic lymphadenopathy with dysproteinemia. Cancer 1977; 40: 2152–2160
   PubMed Web of Science ®Google Scholar
• Asher R, Burgher LW, Feagler JR. Immunoblastic lymphadenopathy presenting as pulmonary interstitial fibrosis. J Am Med Assoc 1977; 237: 2411–2412
   Web of Science ®Google Scholar
• Cullen MH, Stansfeld AG, Oliver RTD, et al. Angioimmunoblastic lymphadenopathy: report often cases and review of the literature. Quart J Med New Series XL VIII 1979; 189: 159–177
   Google Scholar
• Tsung SH, Lin JI. Angioimmunoblastic lymphadenopathy in a patient taking diphenylhydantoin. Ann Clin Lab Sci 1981; 11: 542–545
   PubMed Web of Science ®Google Scholar
• Espinosa G, Mulligan BD. Radiographic presentation of angioimmunoblastic lymphadenopathy: case report. Milit Med 1981; 146: 58–60
   PubMed Web of Science ®Google Scholar
• Averback P, Salama SS, Moinuddin M. Hashimoto's thyroiditis with immunoblastic lymphadenopathy and unusual “macaroni cells.”. Can Med Assoc J 1977; 117: 41–43
   PubMed Web of Science ®Google Scholar
• Watanabe H. Association of immunoblastic lymphadenopathy and Hashimoto's thyroiditis. Ann Intern Med 1977; 87: 62–64
   PubMed Web of Science ®Google Scholar
• Krugliak L, Zimlichman RR, Schlaeffer F, et al. Immunoblastic lymphoma and thymic epithelial hyperplasia in angioimmunoblastic lymphadenopathy following gold therapy. Isr J Med Sci 1985; 21: 381–385
   PubMedGoogle Scholar
• Kardon FM, Sibone P, Lopez JA, et al. Angioimmunoblastic lymphadenopathy with weitis. AM Ophthalmol 1982; 14: 915–918
   Google Scholar
• Pope RM, Cederbaum AI, Lewis W, et al. Immunoblastic lymphadenopathy presenting as respiratory insufficiency. Am J Med Sci 1977; 274: 213–219
   PubMed Web of Science ®Google Scholar
• Shaw RA, Schonfeld SA, Whitcomb ME. A perplexing case of hilar adenopathy. Chest 1981; 80: 736–740
   PubMed Web of Science ®Google Scholar
• Vohra RM, Patel AR, Khandepeular RV, et al. Immunoblastic lymphadenopathy with upper respiratory obstruction. AM Intern Med 1977; 86: 830–831
   Web of Science ®Google Scholar
• Bello I, Paya C, Ruilope LM, et al. Angioimmunoblastic lymph-adenopathy ad transient Fanconi syndrome. Nephron 1985; 39: 275–276
   PubMed Web of Science ®Google Scholar
• Wood WG, Harkins MH. Nephropathy in angioimmunoblastic lymphadenopathy. Am J Clin Pathol 1979; 71: 58–63
   PubMed Web of Science ®Google Scholar
• Bhat JG, Kerpan HO, Murthy PS, et al. Angioimmunoblastic lymphadenopathy, Beme Jones proteinuria and acute renal failure. Arch Intern Med 1981; 141: 1373–1374
   PubMed Web of Science ®Google Scholar
• Moore BS, Harrison LG, Wieland LH. Angioimmunoblastic lymphadenopathy. Mayo Clin Proc 1976; 51: 273–280
   PubMed Web of Science ®Google Scholar
• O'Donnell PP, Jiji R, Vigorito R, et al. Angioimmunoblastic lymphadenopathy: its Occurrence and meningeal involvement. Arch Neurol 1980; 37: 598–599
   PubMed Web of Science ®Google Scholar
• Tredici G, Minazzi M, Lampugnani E. Peripheral neuropathy in angioimmunoblastic lymphadenopathy with dysproteinuria. J Neurol Neurosurg Psych 1979; 42: 519–523
   PubMed Web of Science ®Google Scholar
• Mazur EM, Hen DH, Enriquez RE, et al. Angioimmunoblastic lymphadenopathy evolution to a Burkitt-like lymphoma. Am J Med 1979; 67: 317–324
   PubMed Web of Science ®Google Scholar
• Cytowic RE, Challa YR, Buss DH, et al. Chronic relapsing ply-neuropathy assxiated with immunoblastic lymphadenopathy. Human Pathol 1982; 13: 167–169
   PubMed Web of Science ®Google Scholar
• Kalus MJ. Immnoblastic lymphadenopathy: a report of two cases. Arch Pathol Lab Med 1976; 100: 465–468
   PubMed Web of Science ®Google Scholar
• Narasimhan P, Ahn BH, Levy RN, et al. Immunoblastic lymphadenopathy: high serum toxoplasma titer. NY State J Med 1979; 79: 241–244
   PubMedGoogle Scholar
• Monteiro ML, Coppeto JR, Greco P, et al. Angioimmunoblastic lymphadenopathy with Fisher syndrome. Arch Neurol 1984; 41: 456–457
   PubMed Web of Science ®Google Scholar
• Seigneurin J, Mingat J, Lenoir GM, et al. Angioimmunoblastic lymphadenopathy after infectious mononucleosis. Br Med J 1981; 282: 1574–1575
   PubMed Web of Science ®Google Scholar
• Deeg H, Singer JW, Huang TW. Angioimmunoblastic lymphadenopathy with retinitis and drug-related exacerbations: a clinicopathological case study. Cancer 1979; 44: 1745–1750
   PubMed Web of Science ®Google Scholar
• Gleichmann E, Van Elven Gleichman F. Immunoblastic lymphadenopathy, systemic lupus erythematosus and related disorders-possible pathogenetic pathways. Am J Clin Pathol 1979; 72: 708–723
   PubMed Web of Science ®Google Scholar
• Schultz DR, Yunis AA. Immunoblastic lymphadenopathy with mixed cryoglobulinemia: a detailed case report. N Engl J Med 1975; 292: 9–12
   Web of Science ®Google Scholar
• Shamoto M, Suchi T. Intracytoplasmic type A virus-like particles in angioimmunoblastic lymphadenopathy. Cancer 1979; 44: 1641–1643
   PubMed Web of Science ®Google Scholar
• Bornkmann GW, Stein H, Lennen K, et al. Attempts to demonstrate viral specific sequences in human tumofs. N. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis. Int J Cancer 1976; 17: 177–181
   PubMed Web of Science ®Google Scholar
• Krueger GR, Bergholz M, Bansch HH, et al. Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymph-adenopathy. J Cancer Res Clin Oncol 1979; 95: 87–91
   PubMed Web of Science ®Google Scholar
• Krueger GR, Konorza G. Angioimmunoblastic lymphadenopathy in persistent virus infection?. Lancet 1977; 1135
   PubMed Web of Science ®Google Scholar
• Senitzer D, Gibbons J, Gohara A, et al. Infectious antecedent of immunoblastic lymphoma. Progressive immunosuppression in a patient with lymphogranuloma venereum. Am J Med 1985; 78: 163–167
   PubMed Web of Science ®Google Scholar
• Karttunen T, Nevasaari K, Rasanen O, et al. Immunoblastic lymphadenopathy with a high serum Yersrnia enterocolitica titer. Cancer 1983; 52: 2281–2284
   PubMed Web of Science ®Google Scholar
• Warner M, Masur H, Jarowski CI, et al. Angioimmunoblastic lymphadenopathy associated with chronic Plasmodium malariae infection. Arch Intern Med 1981; 141: 1692–1694
   PubMed Web of Science ®Google Scholar
• Ironside P, Cornell FN. Immunoblastic lymphadenopathy. A clinicopathological study of 16 cases. Pathology 1979; 11: 27–37
   PubMed Web of Science ®Google Scholar
• Flandrin G. Angioimmunoblastic lymphadenopathy: clinical. biologic and follow-up study of 14 cases. Rec Res Cancer Res 1978; 64: 247–262
   PubMedGoogle Scholar
• Rothwell RS, Mant MJ, Davis P. Angioimmunoblastic lymphadenopathy associated with polyarthritis. Ann Rheum Dis 1980; 39: 406–409
   PubMed Web of Science ®Google Scholar
• Levey IL, Unpublished observations
   Google Scholar
• Schechter SL, Rosenblum D. Immunoblastic lymphadenopathy and hydroxychloroquhe. Arthritis Rheum 1980; 23: 256–257
   PubMed Web of Science ®Google Scholar
• Berris B., Fernandes B, Rother I. Immunoblastic lymphadenopathy: report of four new cases and review of the disease. Can Med Assoc J 1982; 127: 389–392
   PubMed Web of Science ®Google Scholar
• Coupland RW, Pontifex AH, Salinas FA. Angioimmunoblastic lymphadenopathy with dysproteinemia. Circulating immune complexes and review of eighteen cases. Cancer 1985; 55: 1902–1906
   PubMed Web of Science ®Google Scholar
• Sadovsky R, Zazakos C. Angioimmunoblastic lymphadenopathy, Common symptoms. uncommon disease. Postgrad Med 1977; 62: 213–216
   PubMed Web of Science ®Google Scholar
• Entrican JH, Denberg JA, Gauldie J, et al. Angioimmunoblastic lymphadenopathy Associated with reserpine. Lancet 1984; ii: 820–821
   Google Scholar
• Smith MA, Youngs GR. Angioimmunoblastic lymphadenopathy, sulphasalazine exposure and villous atrophy. Postgrad Med J 1985; 61: 337–338
   PubMed Web of Science ®Google Scholar
• Offitt K, Macris NT. Arsenic-associated angioimmunoblastic lymphadenopathy. Lancet 1985; 220
   Web of Science ®Google Scholar
• Maguire FW, Mills RC, Parker FP. Immunoblastic lymphadenopathy and asbestosis. Cancer 1981; 47: 791–797
   PubMed Web of Science ®Google Scholar
• Newcom SR, Kadin ME. Prednisone in treatment of allergen-associated angioimmunoblastic lymphadenopathy. Lancet 1979; i: 462–464
   Google Scholar
• Gold JA, Sibbald RG, Phillips MJ, et al. Angioimmunoblastic lymphadenopathy following typhoid AB vaccination and terminating in disseminated infection. Arch Pathol Lab Med 1985; 109: 1085–1088
   PubMed Web of Science ®Google Scholar
• Bensa JC, Faure J, Martin H, et al. Levamisole in angioimmunoblastic lymphadenopathy. Lancet 1976; 1081
   PubMed Web of Science ®Google Scholar
• Ellergard J, Boesen AM. Restoration of defective cellular immunity by levamisole in a patient with immunoblastic Iymphadenopathy. Scand J Haematol 1976; 17: 36–43
   PubMedGoogle Scholar
• Garam T, Bak M, Bakacs T, et al. Angioimmunoblastic lymphadenopathy: a study of the function of lymphocyte populations. Cancer 1981; 47: 2850–2855
   PubMed Web of Science ®Google Scholar
• Kosmidis PA, Axelrod AR, Palacas C, et al. Angioimmunoblastic lymphadenopathy: a T-cell deficiency. Cancer 1978; 42: 447–452
   PubMed Web of Science ®Google Scholar
• Taylor SC. Lymphocyte responsiveness to thymosin in angioimmunoblastic lymphadenopathy with lymphomatous transformation. Med Pediatr Oncol 1982; 10: 171–114
   PubMedGoogle Scholar
• Prchal JT, Crago SS, Mestecky J, et al. Imrnunoblastic lymphadenopathy: animmunologic study. Cancer 1981; 47: 2312–2318
   PubMed Web of Science ®Google Scholar
• Rudders RA, DeLellis R. Immunoblastic lymphadenopathy: a mixed proliferation of T and B lymphocytes. Am J Clin Pathol 1977; 68: 518–521
   PubMed Web of Science ®Google Scholar
• Skibin A, Yerdyahu T, Keynan A, et al. Immunological studies in angioimmunoblastic lymphadenopathy. Clin Exp Immunol 1980; 39: 386–394
   PubMed Web of Science ®Google Scholar
• Saern M, Aelion JA, Lurie Y, et al. Angioimmunoblastk lymphadenopathy and squamous cell carcinoma of lung. Am J Med 1984; 287: 21–23
   Google Scholar
• Yoshimoto S, Yano S, Yamashita M, et al. Epstein-Barr virus-positive primary brain lymphoma complicating immunoblastic lymphadenopathy. Acta Haematol 1985; 74: 114–115
   PubMed Web of Science ®Google Scholar
• Rubinstein A, Dauber LG. Lymphoma of cytotoxic/suppressor phenotype (T8) following angioimmunoblastic lymphadenopathy. Oncology 1983; 40: 195–199
   PubMed Web of Science ®Google Scholar
• Honda M, Smith HR, Steinberg AD. Studies of the pathogenesis of angioimmunoblastic lymphadenopathy. J Clin Invest 1985; 76: 332–340
   PubMed Web of Science ®Google Scholar
• Blumenfeld W, Beckstead JH. Angioimmunoblastic lymphadenopathy with dysproteinemia in homosexual men with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1983; 107: 567–569
   PubMed Web of Science ®Google Scholar
• Soupart A, de Saint-Georges A, Salhadin A, et al. Angioimmunoblastic lymphadenopathy with paraproteinemia. Analysis of the clinical and biological characteristics and their prognostic significance. Arch Intern Med 1984; 114: 2092–2093
   Google Scholar
• Watanabe S, Sato Y, Shimoyama M, et al. Immunoblastic lymphadenopathy, angioimnoblastic lymphadenopathy, and IBL-like T-cell lymphoma. A spectrum of T-cell neoplasia. Cancer 1986; 58: 2224–2232
   PubMed Web of Science ®Google Scholar
• Paloczi K, Surany P, Nemes Z, et al. A study of lymphocyte subsets in patients with angioimmunoblastic lymphadenopathy. Br J Haematol 1986; 62: 615–618
   PubMed Web of Science ®Google Scholar
• Bignon YJ, Janin-Mercer A, Dubst JJ, et al. Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) and sicca syndrome. Ann Rheum Dis 1986; 45: 519–522
   PubMed Web of Science ®Google Scholar
• Pirker R, Schwarzmeier JD, Radaszkiewicz T, et al. B-immunoblastic lymphoma arising in angioimmunoblastic lymphadenopathy. Acta Haematol 1986; 75: 105–109
   PubMed Web of Science ®Google Scholar
• Gray RG. Synovial fluid lymphocyte subpopulations in the plyarthritis of immunoblastic lymphadenopathy. Arthritis Rheum 1985; 28: 120
   PubMed Web of Science ®Google Scholar
• Ligler FS, Patel M, Strayer D, et al. Extremely high levels of natural killer cells in angioimmunoblastic lymphadenopathy. J Clin Immunol 1983; 3: 375–381
   PubMed Web of Science ®Google Scholar
• Pizzolo G, Semenzato G, Chilosi M, et al. Distribution and heterogeneity of cells detected by HNK-I and monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions. Clin Exp Immunol 1984; 57: 195–206
   PubMed Web of Science ®Google Scholar
• Masur H, Michelis MA, Green JB, et al. An outbreak of community-acquired Pneumocystis carinü pneumonia. Initial manifestations of cellular immune dysfunction. N Engl J Med 1981; 305: 1431–1438
   PubMed Web of Science ®Google Scholar
• Ioachim HL, Lerner CW, Tapper ML. The lymphoid lesions associated with acquired immunodeficiency syndrome. Am J Surg Pathol 1983; 7: 543–553
   PubMed Web of Science ®Google Scholar
• Metroka CE, Cunnigham-Rundles S, Pollak MS, et al. Generalized lymphadenopathy in homosexual men. Ann Intern Med 1983; 99: 585–591
   PubMed Web of Science ®Google Scholar
• Friedman-Birnbaum R, Gilhar A, Carter A. Co-existence of Kaposi's sarcoma and angioimmunoblastic lymphadenopathy. J Dermatol Surg Oncol 1985; 11: 76–79
   PubMedGoogle Scholar
• Kluin-Nelem HC, Elbers HRJ, Ramselaar CG. Angioimmunoblastic lymphadenopathy followed by Kaposi's sarcoma. Arch Dermatol 1984; 120: 958–959
   PubMed Web of Science ®Google Scholar
• Solan AJ, Greenwald ES, Silvay O. Long-term remissions of Kaposi's sarcoma with vinblastine therapy. Cancer 1981; 47: 637–639
   PubMed Web of Science ®Google Scholar
• Tosi P, Auteri A, Cintorino M, et al. Angioimmunoblastic lymphadenopathy with dysproteinemia complicated by Kaposi's sarcoma. Tumori 1979; 65: 363–371
   PubMed Web of Science ®Google Scholar
• Varsano S, Manor Y, Steiner Z, et al. Kaposi's sarcoma and angioimmunoblastic lymphadenopathy. Cancer 1984; 54: 1582–1585
   PubMed Web of Science ®Google Scholar
• Al-Jitawa S, Jumean H, Omeish OY. Kaposi's sarcoma and angioimmunoblastic lymphadenopathy. Clin Exp Dermatol 1985; 10: 404
   Web of Science ®Google Scholar
• Fayemi AO, Ali M, Bmun EV, et al. Angioimmunoblastic lymphadenopathy: termination as diffuse lymphosarcoma with plasma-cytoid features. Mt Sinai J Med 1979; 46: 39–43
   PubMed Web of Science ®Google Scholar
• Pierce DA, Stern R, Jaffe R, et al. Immuncblastic sarcoma with features of Sjogren's syndrome and systemic lupus erythematosus in a patient with immunoblastic lymphadenopathy. Arthritis Rheum 1979; 22: 911–916
   PubMed Web of Science ®Google Scholar
• Kreisler JM, Moreno E, Moneo I, et al. Immunologic findings in immunoblastic lymphadenopathy. Clin Exp Immunol 1977; 27: 497–501
   PubMed Web of Science ®Google Scholar
• Barnes HM, Poon MC, Huang ST, et al. Febrile transfusion reaction following initial transfusion in a man with immunoblastic lymphadenopathy and granulocyte autoantibodies. Am J Hematol 1983; 14: 97–100
   PubMed Web of Science ®Google Scholar
• Andrieu JM, Youinou P, Herzog C. Levamisole and autoimmunity in angioimmunoblastic lymphadenopathy. Acta Haematol 1979; 62: 117–118
   PubMed Web of Science ®Google Scholar
• Dellagi K, Brouet JC, Seligmann M. Antivimntin autoantibodies in angioimmunoblastic lymphadenopathy. N Engl J Med 1981; 310: 215–218
   Web of Science ®Google Scholar
• Fuginami RS, Oldstone MBA, Wrobbeoska Z, et al. Cross-reaction of measles virus phosphoprotein or of herpes simplex protein with human intermediate filaments. Proc Natl Acad Sci (USA) 1980; 80: 12346–2351
   Google Scholar
• Schechter SL. Case 11-1980: Differentiating systemic lupus erythematosus from angioimmunoblastic lymphadenopathy. N Engl J Med 1980; 303: 396–397
   PubMed Web of Science ®Google Scholar
• Popa G, Nastase V, Hanganu E. Angioimmunoblastic lymphadenopathy associated with systemic lupus erythematosus. Folia Haematol 1982; 109: 430–434
   Google Scholar
• Londino AV, Luparello FJ. Factor XII deficiency in a man with gout and angioimmunoblastic lymphdenopathy. Arch Intern Med 1984; 144: 1497–1499
   PubMed Web of Science ®Google Scholar
• Davies PG, Fordham JN. Arthritis and angioimmunoblastic lymphadenopathy. Ann Rheum Dis 1983; 42: 516–518
   PubMed Web of Science ®Google Scholar
• Warlow R, Vernea S, Mijch A. Angioimmunoblastic lymphadenopathy Associated with large muscle arteritis. Human Pathol 1984; 15: 486–490
   PubMed Web of Science ®Google Scholar
• Madri JA, Fromwitz F. Amyloid deposition in immunoblastic lymphadenopathy. Human Pathol 1978; 9: 157–162
   PubMed Web of Science ®Google Scholar
• Plavnick L, Weiner P, Perzner S, et al. Amyloidosis in immunoblastic lymphadenopathy. Isr J Med Sci 1980; 16: 599–603
   PubMedGoogle Scholar
• Gindhart TD, Greenspan JS. Angioimmunoblastic lymphadenopathy with dysproteinemia. Animal model: preneoplastic lymphoid hyperplasia in autoimmune New Zealand mice. Am J Pathol 1980; 99: 805–808
   PubMed Web of Science ®Google Scholar
• Prud'homme GJ, Park CL, Fieser TM, et al. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. J Exp Med 1983; 157: 730–742
   PubMed Web of Science ®Google Scholar
• Roths JB, Murphy ED, Eicher EM. A new mutation, gld that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J Exp Med 1984; 159: l–20
   Web of Science ®Google Scholar
• Yerganian G, Gagnon HJ, Battaglino A. Angioimmunoblastic lymphadenopathy, immunoblastic sarcoma of B cells. Animal model: autoimmune-prone inbred Armenian hamster. Am J Pathol 1978; 91: 209–212
   PubMed Web of Science ®Google Scholar
• Krueger GRF, Malmgren RA, Berard CW. Malignant lymphomas and plasmacytosis in mice under prolonged immunosuppression and persistent antigenic stimulation. Transplantation 1971; 11: 138–144
   PubMed Web of Science ®Google Scholar
• Volk SLR, Montelcone PL, Knight WAK. Chromosomes in AILD. N Engl J Med 1975; 292: 975
   PubMed Web of Science ®Google Scholar
• Hossfield DK, Hoffken K, Schmidt CG, et al. Chromosome abnormalities in angioimmunoblastic lymphadenopathy. Lancet 1976; 198
   Web of Science ®Google Scholar
• Goh KO, Bakaneier RF. Is angioimmunoblastic lymphadenopathy with dysproteinemia a malignant disease?. J Am Med Worn Assoc 1978; 33: 38–40
   PubMedGoogle Scholar
• Mountz JD, Mushinski JF, Smith HR, et al. Modulation of c-myb transcripion in autoimmune disease by cyclophosphamide. J Immunol 1985; 135: 2417–2422
   PubMed Web of Science ®Google Scholar
• Klinman DM, Steinberg AD, Mushinski IF. Effect of cyclophosphamide therapy on oncogene expression in angioimmunoblastic lymphadenopathy. Lancet 1986; ii: 1055–1057
   Google Scholar
• Balduini CL, Invernizzi R, Castello A, et al. Spontaneous long-lasting remission in a young patient with angioimmunoblastic lymphadenopathy with dysproteinemia. Haematologica 1985; 70: 36–58
   Web of Science ®Google Scholar
• Lopez-Berestein G, Cabanillas F, Osborne BM, et al. Study of the natural history of immunoblastic lymphadenopathy and atypical immunoproliferative disorders. Cancer Invest 1983; 1: 293–299
   PubMed Web of Science ®Google Scholar
• Pangalis GA, Moran EM, Nathwani BN, et al. Angioimmunoblastic lymphadenopathy. Long-term follow-up study. Cancer 1983; 52: 1318–321
   Web of Science ®Google Scholar
• Churchill WH, David JR. Levamisole and cell-mediated immunity. N Engl J Med 1973; 289: 375–378
   PubMed Web of Science ®Google Scholar
• Symoens J, Rosenthal M. Levamisole in the modulation of the immune response: the current experimental and clinical state. J Reticuloendothelial Soc 1977; 21: 175–221
   PubMedGoogle Scholar
• Goldstein AL, Zata MM, Low TL, et al. Potential role of thymosin in the treatment of autoimmune diseases. Ann NY Acad Sci 1981; 377: 486–495
   PubMed Web of Science ®Google Scholar
• Kalan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170
   PubMedGoogle Scholar
• Faravelli A, Sironi M, Vicori A, et al. Angioimmunoblasric lymphadenopathy: a case report with subsequent evolution into a lymphoplasmacytic lymphoplasmacytoid malignant lymphoma. Tumori 1982; 68: 265–270
   PubMed Web of Science ®Google Scholar
• Weis JW, Winter MW, Phyliky RL, et al. Peripheral T-cell lymphomas: histologic. immunohistologic, and clinical characterization. Mayo Clin Proc 1986; 61: 411–426
   PubMed Web of Science ®Google Scholar
• Yatanagas X, Papadimitriou N, Pangalis GA, et al. Angioimmunoblastic lymphadenopathy terminating as Hodgkn's disease. Cancer 1977; 39: 2183–2189
   PubMed Web of Science ®Google Scholar
• D'Arrigo A, Lazzari G, Fornari G, et al. Hodgkin's disease developing in a patient with angioimmunoblastic lymphadenopathy with dysproteinemia—a case report. Tumori 1985; 71: 305–310
   PubMed Web of Science ®Google Scholar
• Periera A, Cervantes F, Vinolas N, et al. Sequential appearance of immunoblastic lymphoma and acute nonlymphocytic leukemia in a patient with angioimmunoblastic lymphadenopathy. Acta Haematol 1985; 74: 175–177
   PubMed Web of Science ®Google Scholar
• Banik S, Ward RL, Hasleton PS. Immunoblastic lymphadenopathy: evolution into immunoblastic sarcoma. J Clin Pathol 1979; 32: 1110–1120
   PubMed Web of Science ®Google Scholar
• Salmon SE, Seligmann M. B-cell neoplasia in man. Lancet 1974; ii: 1230–1233
   Google Scholar
• Shimoyama M, Minato K, Saito H, et al. Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma. Jpn J Clin Oncol 1979; 9: 347–356
   Web of Science ®Google Scholar
• Benness V, Kirsch I, Hollis G, et al. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med 1985; 313: 534–538
   PubMed Web of Science ®Google Scholar
• Weiss LM, Strickler JG, Dorfman RF, et al. Clod T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol 1986; 122: 392–397
   PubMed Web of Science ®Google Scholar